Windtree Therapeutics (NASDAQ:WINT) is a biotechnology company focused on the development of therapeutics and diagnostics for the healthcare sector, particularly in the areas of acute pulmonary and cardiovascular diseases. Known for its passion for innovation, Windtree is advancing a broad range of projects aimed at addressing unmet medical needs. Among its key initiatives is the development of a unique surfactant therapy for acute respiratory conditions, as well as advancing its portfolio of early-stage programs targeting heart failure. The company’s objective is to transform the therapeutic landscape through the advancement of novel technologies and drugs that improve patient outcomes in critical care settings. Windtree Therapeutics is dedicated to pioneering new solutions that could potentially save lives and improve the quality of life for patients around the globe.